Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.34NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
FL.34NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FL.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.34NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.34NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.34NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FL.34NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FL.34NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FL.34NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
FL.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.34NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HY.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
HY.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
HY.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HY.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
HY.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HY.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
HY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HY.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HY.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
HY.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HY.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HY.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
HY.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
HY.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HY.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
HY.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
HY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HY.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JC.5NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
JC.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
JC.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JC.5NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
JC.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JC.5NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
JC.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
JC.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JC.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JC.5NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
JC.5NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used